Incredible success of Christopher Nolan's masterwork 'Oppenheimer,' Kashmiri theatres are once again in the spotlight. Inox Srinagar has been exceeding expectations just like the rest of the country because to this Hollywood gem.
(Also Read: Oppenheimer Advance Booking In India Day 1: 8.20K+ Tickets Per Hour Sold Online While 3 National Cinema Chains Block A Sale Of 1.50 Lakh+ Tickets Already!)
Industry experts predict that 'Oppenheimer' may challenge, or at least come extremely close to, Shah Rukh Khan's 'Pathaan' collections at Inox Srinagar given the huge response. Vikas Dhar is cautiously optimistic though, recognising Shah Rukh Khan's unrivalled fan base in the area. His latest movie, Jawan, is already generating a lot of interest, demonstrating the actor's ongoing reputation in Kashmir.
'Oppenheimer' is enthralling spectators at Inox Srinagar with four daily shows in English and one with Hindi subs. Vikas Dhar emphasises that Kashmiri audiences have acquired an international taste in cinema by pointing to the region's fervent fandom for Christopher Nolan and Cillian Murphy.
(Also Read: Oh No! Chris Hemsworth Caught 'Emmerdale' Actor Picking His Nose On Toilet Seat! (Details Inside))
The nationwide box office performance of 'Oppenheimer', which raked in approximately Rs. 30 crores in just two days, has been nothing short of astonishing. A blockbuster hit, the movie has a good possibility of surpassing the Rs. 100 crore milestone thanks to its increasing popularity.
About The Author
For the latest Bollywood news, Telugu news,entertainment exclusives,gossip ,movie reviews , and more Read More
For the latest Bollywood news, Telugu news,entertainment exclusives,gossip ,movie reviews , and more, follow the BollywoodMDB website and YouTube channel, or head to our social media platforms like Twitter, Facebook, Instagram! For the latest Bollywood news, Telugu news,entertainment exclusives,gossip ,movie reviews , and more, follow the BollywoodMDB website and YouTube channel, or head to our social media platforms like Twitter, Facebook, Instagram!
Read Less